Concepedia

Clinical outcomes of ovarian cancer patients treated with the novel engineered cytokine nemvaleukin alfa in combination with the PD-1 inhibitor pembrolizumab: recent data from ARTISTRY-1 (077)

Ira Winer, Ulka N. Vaishampayan, Lucy Gilbert, Seth Rosen, Shipra Gandhi, Yan Wang, Yangchun Du, Lei Sun, Rita Dalal, Monali Desai,

Gynecologic Oncology · 2022 · 10 citations · 0 references

DOI

Concepts